Annual EBIT:
-$192.40M-$107.75M(-127.27%)Summary
- As of today, MLYS annual earnings before interest & taxes is -$192.40 million, with the most recent change of -$107.75 million (-127.27%) on December 31, 2024.
- During the last 3 years, MLYS annual EBIT has fallen by -$173.02 million (-892.74%).
- MLYS annual EBIT is now -5711.02% below its all-time high of -$3.31 million, reached on December 1, 2020.
Performance
MLYS EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
-$46.75M-$2.30M(-5.17%)Summary
- As of today, MLYS quarterly earnings before interest & taxes is -$46.75 million, with the most recent change of -$2.30 million (-5.17%) on June 30, 2025.
- Over the past year, MLYS quarterly EBIT has dropped by -$1.58 million (-3.49%).
- MLYS quarterly EBIT is now -621.50% below its all-time high of -$6.48 million, reached on June 1, 2022.
Performance
MLYS Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$203.07M-$1.58M(-0.78%)Summary
- As of today, MLYS TTM earnings before interest & taxes is -$203.07 million, with the most recent change of -$1.58 million (-0.78%) on June 30, 2025.
- Over the past year, MLYS TTM EBIT has dropped by -$68.55 million (-50.96%).
- MLYS TTM EBIT is now -2766.95% below its all-time high of -$7.08 million, reached on December 1, 2021.
Performance
MLYS TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
MLYS EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -127.3% | -3.5% | -51.0% |
| 3Y3 Years | -892.7% | -621.5% | -1397.3% |
| 5Y5 Years | -5711.0% | -560.0% | -2766.9% |
MLYS EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -892.7% | at low | -529.8% | +22.2% | -867.7% | at low |
| 5Y | 5-Year | -5711.0% | at low | -621.5% | +22.2% | -2766.9% | at low |
| All-Time | All-Time | -5711.0% | at low | -621.5% | +22.2% | -2766.9% | at low |
MLYS EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$46.75M(-5.2%) | -$203.07M(-0.8%) |
| Mar 2025 | - | -$44.45M(+14.1%) | -$201.49M(-4.7%) |
| Dec 2024 | -$192.40M(-127.3%) | -$51.77M(+13.9%) | -$192.40M(-14.3%) |
| Sep 2024 | - | -$60.11M(-33.1%) | -$168.35M(-25.2%) |
| Jun 2024 | - | -$45.17M(-27.7%) | -$134.51M(-28.0%) |
| Mar 2024 | - | -$35.36M(-27.6%) | -$105.08M(-24.1%) |
| Dec 2023 | -$84.66M | -$27.71M(-5.5%) | -$84.66M(-26.4%) |
| Sep 2023 | - | -$26.27M(-67.0%) | -$66.95M(-39.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$15.73M(-5.3%) | -$48.10M(-23.8%) |
| Mar 2023 | - | -$14.94M(-49.3%) | -$38.85M(-62.5%) |
| Dec 2022 | -$31.48M(-62.4%) | -$10.01M(-34.8%) | -$23.91M(-13.9%) |
| Sep 2022 | - | -$7.42M(-14.6%) | -$20.98M(-54.7%) |
| Jun 2022 | - | -$6.48M(+8.5%) | -$13.56M(-91.5%) |
| Dec 2021 | -$19.38M(-485.4%) | - | - |
| Dec 2021 | - | -$7.08M | -$7.08M |
| Dec 2020 | -$3.31M | - | - |
FAQ
- What is Mineralys Therapeutics, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Mineralys Therapeutics, Inc.?
- What is Mineralys Therapeutics, Inc. annual EBIT year-on-year change?
- What is Mineralys Therapeutics, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Mineralys Therapeutics, Inc.?
- What is Mineralys Therapeutics, Inc. quarterly EBIT year-on-year change?
- What is Mineralys Therapeutics, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Mineralys Therapeutics, Inc.?
- What is Mineralys Therapeutics, Inc. TTM EBIT year-on-year change?
What is Mineralys Therapeutics, Inc. annual earnings before interest & taxes?
The current annual EBIT of MLYS is -$192.40M
What is the all-time high annual EBIT for Mineralys Therapeutics, Inc.?
Mineralys Therapeutics, Inc. all-time high annual earnings before interest & taxes is -$3.31M
What is Mineralys Therapeutics, Inc. annual EBIT year-on-year change?
Over the past year, MLYS annual earnings before interest & taxes has changed by -$107.75M (-127.27%)
What is Mineralys Therapeutics, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of MLYS is -$46.75M
What is the all-time high quarterly EBIT for Mineralys Therapeutics, Inc.?
Mineralys Therapeutics, Inc. all-time high quarterly earnings before interest & taxes is -$6.48M
What is Mineralys Therapeutics, Inc. quarterly EBIT year-on-year change?
Over the past year, MLYS quarterly earnings before interest & taxes has changed by -$1.58M (-3.49%)
What is Mineralys Therapeutics, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of MLYS is -$203.07M
What is the all-time high TTM EBIT for Mineralys Therapeutics, Inc.?
Mineralys Therapeutics, Inc. all-time high TTM earnings before interest & taxes is -$7.08M
What is Mineralys Therapeutics, Inc. TTM EBIT year-on-year change?
Over the past year, MLYS TTM earnings before interest & taxes has changed by -$68.55M (-50.96%)